In celebration of having now sequenced the exomes of over 50,000 individuals, GeneDx invites you to join us for our Exome Sprint Series. This program will consist of three 30 minute webinar presentations followed by question and answer looking behind the scenes of our XomeDx program and what makes it so unique.
Webinar One: Exomes the GeneDx Way – Click here to view!
Presented by Ben Solomon, MD, FACMG – Managing Director, GeneDx
Thursday, February 23rd at 12:30 PM – 1:30 PM ET
In a recent interview, GeneDx’s new Managing Director, Dr. Ben Solomon, said the following about GeneDx’s exome sequencing program, “As a pediatric geneticist, I have always known GeneDx to be the gold standard in exome sequencing, but since coming on board recently and getting to ‘look under the hood,’ I have been blown away by the exome service we provide.” Learn more about Dr. Solomon’s experience with clinical exome sequencing, including how these types of tests alter the diagnostic approach, as well as an introduction to GeneDx’s exome services.
About the speaker: Ben Solomon is a board-certified pediatric geneticist who focuses on the use of genetics and genomics to identify, understand and care for patients with both rare and common genetic conditions as well as broad applications of genomic medicine. In addition to his laboratory, clinical, and research leadership and advocacy, Dr. Solomon has authored over 100 peer-reviewed articles, book chapters, and textbooks, and is an active lecturer and educator. Dr. Solomon attended medical school at the Geisel School of Medicine at Dartmouth, completed his residency and fellowship training in pediatrics and clinical genetics at the National Human Genome Research Institute at the National Institutes of Health and at Children’s National Medical Center, and served as Chief of the Division of Medical Genomics at the Inova Translational Medicine Institute.
Webinar Two: The Evolution from Candidate Gene to Disease Gene – Click here to view!
Presented by Lindsay B. Henderson, PhD, DABMGG – Assistant Director, Clinical Genomics Program &
Dustin Baldridge, MD, PhD – Department of Pediatrics, Washington University in St. Louis
Thursday, March 2nd at 12:30 PM – 1:30 PM ET
GeneDx is currently assisting over 60 national and international collaborators on research involving over 80 new candidate genes with the goal of helping referring clinicians provide explanations for their patients, while also allowing for more informed medical care. In 2016 alone, GeneDx assisted clinicians and academicians in publishing 21 articles based on exome sequencing, including 18 articles discussing “new disease genes.” Learn from the Assistant Director of our Clinical Genomics Program, Dr. Lindsay Henderson, about the process of identifying candidate genes, and how GeneDx works with clinicians throughout this process by discussing a recent collaboration with Dr. Dustin Baldridge of Washington University in St. Louis.
About the speaker: Lindsay Henderson joined the Clinical Genomics Program at GeneDx in 2014. She received her BS in Biochemistry and Molecular Biology from the University of Wisconsin – Eau Claire and her PhD in Human Genetics from the Johns Hopkins University School of Medicine, where her research focused on the role of genetic modifiers in cystic fibrosis. She also pursued her postdoctoral clinical training and research at Johns Hopkins and is ABMGG-certified in Clinical Molecular Genetics and Clinical Cytogenetics. Lindsay is actively involved in postgraduate education at GeneDx, and her additional interests include molecular cytogenetics, gene discovery, and developmental disorders.
About the speaker: Dustin Baldridge, MD, PhD, is a board-certified pediatrician conducting full-time clinical genomics research at Washington University in St. Louis, where he co-directs the Human Genomic Characterization Unit of the Intellectual and Developmental Disabilities Research Center. He is an Instructor in the Division of Newborn Medicine, and is committed to helping children with underlying genetic disorders receive a molecular diagnosis.
Webinar Three: Exomes Are Big Data: Analytical Approaches to Clinical Diagnostics –Click here to view!
Presented by Kyle Retterer, MS – Director, Data Science
Thursday, March 9th at 12:30 PM – 1:30 PM ET
Join our Director of Data Science, Kyle Retterer, as he provides an introductory course into the tools used in the processing, analysis, and meta-analysis of exomes. Learn how GeneDx’s exome analysis systems have been designed hand-in-hand with clinical geneticists to make GeneDx’s exome analysis both highly efficient and robust.
About the speaker: Kyle joined GeneDx in 2010. He leads a team of scientists and engineers developing software tools and analytics for clinical genomics. He holds a B.S. in Physics and an M.S. in Bioinformatics from the University of Maryland. Kyle has authored over 25 peer-reviewed articles on whole exome sequencing and the discovery of novel disease genes. His areas of expertise include assay design, pipeline development, analysis automation, and machine learning. Kyle’s research interests include neurodevelopmental disorders and aortic dissection.